Emerging non-antibody‒drug conjugates (non-ADCs) therapeutics of toxins for cancer treatment
2023 · Acta Pharmaceutica Sinica B · 8 citations
https://doi.org/10.1016/j.apsb.2023.11.029
C
Chenxia Bai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
18
Citations
2
h-index
0
i10-index
Chenxia Bai is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Nanoparticle-Based Drug Delivery & Multiple Myeloma Research and Treatments & Nanoplatforms for cancer theranostics. The author has an h-index of 2, co-authored 9 publications.
Papers by this author
worksDevelopment and optimization of a high-throughput HPLC-MS/MS method for the simultaneous determination of Cedazuridine, Gemcitabine and its metabolite in mouse plasma
2024 · Journal of Chromatography B · 2 citations
https://doi.org/10.1016/j.jchromb.2024.124436
Development and optimization of a high-throughput LC-MS/MS method for the simultaneous determination of Exatecan and its Cathepsin B-sensitive prodrug, and ARV-825 in rat plasma: Application to pharmacokinetic study
2025 · Journal of Pharmaceutical and Biomedical Analysis · 2 citations
https://doi.org/10.1016/j.jpba.2025.116746
Localized chemotherapy through metabolic stabilization and in situ gelation for ratio-locked delivery to maximize cytotoxicity and trigger immune responses
2026 · Chemical Engineering Journal · 0 citations
https://doi.org/10.1016/j.cej.2026.174133
Localized chemotherapy through metabolic stabilization and in situ gelation for ratio-locked delivery to maximize cytotoxicity and trigger immune responses
2026 · Chemical Engineering Journal · 0 citations
https://doi.org/10.1016/j.cej.2026.174133
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat